跳至主要内容
临床试验/NCT02173132
NCT02173132已完成3 期

Acetyl-L-Carnitine Reduces Perceived Work Stress and Improves Work Ability and Work Performance in Hepatic Encephalopathy

University of Catania1 个研究点 分布在 1 个国家目标入组 94 人开始时间: 2010年4月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
3 期
状态
已完成
入组人数
94
试验地点
1
主要终点
work stress

研究概览

简要总结

This study evaluated the effects of acetyl-L-carnitine treatment on Perceived Work Stress, Work Ability and Work Performance in subjects with Hepatic Encephalopathy.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Double (Participant, Investigator)

入排标准

年龄范围
33 Years 至 68 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • overt hepatic encephalopathy (HE) or a history of overt HE

排除标准

  • history of recent alcohol intake; infection; recent antibiotic use or gastrointestinal bleeding; history of recent use of drugs affecting psychometric performances like benzodiazepines, antiepileptics or psychotropic drugs; a history of shunt surgery or transjugular intrahepatic portosystemic shunt for portal hypertension; electrolyte imbalance; renal impairment; hepatocellular carcinoma; severe medical problems such as congestive heart failure, pulmonary disease or neurological or psychiatric disorder that could influence quality of life measurement; inability to perform neuropsycological tests.

研究组 & 干预措施

acetyl-L-carnitine

Active Comparator

2 g acetyl-L carnitine twice a day for 90 days

干预措施: Acetyl-L-carnitine (Drug)

sugar pill

Placebo Comparator

Placebo twice a day for 90 days

干预措施: Placebo (Other)

结局指标

主要结局

work stress

时间窗: 90 days

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Mariano Malaguarnera

Associate Professor

University of Catania

研究点 (1)

Loading locations...

相似试验